Microscopic Kaposiform Hemangioendothelioma With Extensive Lymphangiomatosis

Kaposiform hemangioendothelioma (KHE) is presently classified as a vascular neoplasm of intermediate malignant potential. The clinical course of large, deep-seated tumors is frequently complicated by consumptive coagulopathy and life-threatening hemorrhage, while superficial tumors tend to behave in an indolent manner, with no known reports of distant metastasis. We describe an unusual example of KHE occurring as an incidental microscopic finding, within a background of extensive lymphangioma-like changes. The patient underwent 4 intralesional excisions over a period of 6 years, and the Kaposiform component accounts for less than 5% of the overall tissue excised. The patient remains clinically well with residual disease 5 years after conservative surgery, and there has been no evidence of regional or distant metastasis. Based on existing literature, it appears doubtful that KHE has any metastatic potential at all, which calls into question the appropriateness of its place in the spectrum of malignant vascular neoplasms.

[1]  M. Mihm,et al.  Expression of Prox1, Lymphatic Endothelial Nuclear Transcription Factor, in Kaposiform Hemangioendothelioma and Tufted Angioma , 2010, The American journal of surgical pathology.

[2]  J. Horton,et al.  Kaposiform hemangioendothelioma: a rare cause of spontaneous hemothorax in infancy. Review of the literature. , 2008, Journal of pediatric surgery.

[3]  X. Nie,et al.  Kaposiform hemangioendothelioma: Case report and literature review , 2007 .

[4]  Vincent Vander Poorten,et al.  Multifocal kaposiform haemangioendothelioma , 2006, Virchows Archiv.

[5]  J. Mulliken,et al.  Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon. , 2005, Journal of the American Academy of Dermatology.

[6]  A. Folpe,et al.  Kaposiform Hemangioendothelioma: A Study of 33 Cases Emphasizing Its Pathologic, Immunophenotypic, and Biologic Uniqueness From Juvenile Hemangioma , 2004, The American journal of surgical pathology.

[7]  R. Méndez,et al.  Kaposiform hemangioendothelioma associated with Milroy's disease (primary hereditary lymphedema). , 2003, Journal of pediatric surgery.

[8]  D. Adams,et al.  Kasabach-Merritt Phenomenon: A Retrospective Study of Treatment with Vincristine , 2002, Journal of pediatric hematology/oncology.

[9]  S. Kumta,et al.  Kaposiform Hemangioendothelioma: Five Patients with Cutaneous Lesion and Long Follow-Up , 2001, Modern Pathology.

[10]  A. Folpe,et al.  Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3): A Marker of Vascular Tumors with Presumed Lymphatic Differentiation, Including Kaposi's Sarcoma, Kaposiform and Dabska-Type Hemangioendotheliomas, and a Subset of Angiosarcomas , 2000, Modern Pathology.

[11]  N. Rofsky,et al.  Successful multimodal therapy for kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon: case report and review of the literature. , 1998, Pediatric hematology and oncology.

[12]  A. D. Dei Tos,et al.  Kaposiform hemangioendothelioma in adults. Clinicopathologic and immunohistochemical analysis of three cases. , 1997, American journal of clinical pathology.

[13]  A. Taïeb,et al.  Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. , 1997, The Journal of pediatrics.

[14]  S. Weiss,et al.  Kaposiform Hemangioendothelioma of Infancy and Childhood: An Aggressive Neoplasm Associated with Kasabach-Merritt Syndrome and Lymphangiomatosis , 1993, The American journal of surgical pathology.

[15]  J. Chan,et al.  Kaposi-like infantile hemangioendothelioma. A distinctive vascular neoplasm of the retroperitoneum. , 1991, The American journal of surgical pathology.

[16]  K. Merritt,et al.  CAPILLARY HEMANGIOMA WITH EXTENSIVE PURPURA: REPORT OF A CASE , 1940 .